Interestingly, compared to 4, compound 7 displayed superior binding (Table 2) to both 3R and 4R tau aggregates/tau aggregate folds in self-competition experiments employing recombinant K18 tau fibrils as well as human PSP and PiD brain homogenates. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.